Pfizer Inc (PFE)

PFE (NYSE:Drugs) EQUITY
$34.78
pos +0.01
+0.03%
Today's Range: 0.00 - 0.00 | PFE Avg Daily Volume: 22,154,600
Last Update: 08/25/16 - 3:59 PM EDT
Volume: 0
YTD Performance: 7.71%
Open: $0.00
Previous Close: $34.77
52 Week Range: $28.25 - $37.39
Oustanding Shares: 6,065,652,424
Market Cap: 211,206,017,404
6-Month Chart
TheStreet Ratings Grade for PFE
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 7 9 9 9
Moderate Buy 0 0 0 0
Hold 6 6 6 6
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.92 1.80 1.80 1.80
Latest Dividend: 0.30
Latest Dividend Yield: 3.45%
Dividend Ex-Date: 08/03/16
Price Earnings Ratio: 15.68
Price Earnings Comparisons:
PFE Sector Avg. S&P 500
15.68 30.80 12.90
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
1.22% 10.94% 22.69%
GROWTH 12 Mo 3 Yr CAGR
Revenue -1.50 -0.20 -0.06
Net Income -23.80 -0.30 -0.10
EPS -21.70 -0.40 -0.17
Earnings for PFE:
EBITDA 18.13B
Revenue 48.85B
Average Earnings Estimates
Qtr (09/16) Qtr (12/16) FY (12/16) FY (12/17)
Average Estimate $0.62 $0.53 $2.46 $2.66
Number of Analysts 6 5 10 10
High Estimate $0.65 $0.56 $2.48 $2.80
Low Estimate $0.58 $0.51 $2.43 $2.34
Prior Year $0.60 $0.53 $2.20 $2.46
Growth Rate (Year over Year) 3.89% 0.00% 11.82% 8.13%
Chart Benchmark
Average Frequency Timeframe
Indicator Chart Scale  
Symbol Comparison Bollinger Bands
By

Anders Keitz

 | Aug 24, 2016 | 5:27 PM EDT
Pfizer's second acquisition this week could add risk. Some retailers attract portfolio managers.
By

James "Rev Shark" DePorre

 | Aug 22, 2016 | 4:21 PM EDT
Stocks travel a good distance just to end up nowhere.
By

Bret Jensen

 | Aug 22, 2016 | 4:16 PM EDT
It was nice to fill in for Doug Kass on what was a very uneventful Monday to begin the week. The market traded in an extremely narrow range for the day, and outside the strength in biotech and the weakness in oil after a nice recent rally there really wasn't much of note that happened today. Still, there were some good conversations on the Daily Dairy despite the directionless market.
By

Jim Cramer

 | Aug 22, 2016 | 1:36 PM EDT
That's the hot spot in M&A right now.
By

Bret Jensen

 | Aug 22, 2016 | 11:48 AM EDT
Stocks are back to flat to slightly lower overall, but biotechs are up some 1.5% following the announcement from Pfizer (PFE) of plans to buy Medivation (MDVN) for $14 billion.
By

Bret Jensen

 | Aug 22, 2016 | 10:31 AM EDT
Las Vegas Sands (LVS) continues to show strength after Bank of America/Merrill Lynch put out an optimistic note this morning about Macau gambling. Energy is weak in early trading. Oil has drifted back down to around $47 a barrel following its recent roughly 20% rally.
By

Anders Keitz

 | Aug 22, 2016 | 8:13 AM EDT
Pfizer agrees to acquire Medivation while Citi puts Foot Locker and Under Armour on the back-to-school shopping list.
By

Bret Jensen

 | Aug 22, 2016 | 7:54 AM EDT
Good morning, Bret Jensen here! It's good to be standing in for Doug Kass again on the daily diary as we begin a new trading week.
By

Tim Melvin

 | Aug 16, 2016 | 2:00 PM EDT
These managers have great track records and I have made money stealing their ideas.
By

Tony Owusu

 | Aug 15, 2016 | 5:52 PM EDT
Appaloosa adds to its stake in the biopharmaceutical company while Jana Partners exits its position.
We have followed all areas of the Healthcare industry for decades. And while there are lik...
Shares of Dollar General (DG) got hammered today after fiscal Q2 EPS came in at $1.08 vers...
Before the open today, I noted to our members that crude oil is starting to look and act l...
Stocks continue to meander in very narrow ranges as investors appear hesitant to make any ...

REAL MONEY PRO'S BEST IDEAS

News Breaks

Powered by
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.